Table 1.
Baseline population characteristics at the start of the pandemic and compared by those who did versus did not provide sputum during the pandemic period
| Total (N = 102) | No Samples (n = 63) | ⩾1 Sample (n = 39) | P Value* | |
|---|---|---|---|---|
| Age, yr | 31.0 (25.0–45.3) | 35.5 (26.3–45.0) | 31.0 (23.0–45.3) | 0.367 |
| Sex, male | 62 (60.1) | 40 (63.5) | 22 (57.9) | 0.669 |
| Genotype | — | — | — | 0.367 |
| F508del heterozygous | 45 (44.1) | 28 (44.4) | 17 (43.6) | — |
| F508del homozygous | 39 (38.3) | 22 (34.9) | 16 (41.0) | — |
| Other | 18 (17.6) | 13 (20.1) | 6 (15.4) | — |
| FEV1PP | 77 ± 21 | 77 ± 22 | 75 ± 19 | 0.509 |
| BMI, kg/m2 | 23.1 ± 3.6 | 23.4 ± 3.7 | 22.6 ± 3.5 | 0.252 |
| Pancreatic insufficiency | 76 (74.5) | 45 (71.5) | 31 (79.5) | 0.435 |
| CF-related diabetes | 30 ± 29.4 | 20 ± 31.7 | 10 ± 25.7 | 0.686 |
Definition of abbreviations: BMI = body mass index; CF = cystic fibrosis; FEV1PP = percent predicted of forced expiratory volume in 1 second.
Data are presented as median (interquartile range) when nonnormally distributed, mean ± standard deviation when normally distributed data, and n (%) when categorical.
*
For the comparisons of individuals who did versus did not provide sputum during the pandemic.